The Trump administration has announced new, lower Medicare prices for 15 drugs, including Ozempic, Wegovy, and key cancer treatments, effective in 2027.

The Centers for Medicare & Medicaid Services announced Nov. 25 that Medicare recipients will pay less for 15 prescription ...

The 2026 version of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy report has been published. Key ...

The government said Tuesday that Novo Nordisk's (NVO) drugs - Ozempic and Rybelsus for Type 2 diabetes - will cost $274 for a month's supply in 2027 for people covered by Medicare. Wegovy, which is ...

Medicare is cutting prices on 15 key drugs under the Inflation Reduction Act, offering major savings for seniors while facing ...

The Medicare health plan said on Tuesday that newly negotiated prices for 15 of its costliest drugs will save 36% on those ...

The Trump administration said that had the new prices been in effect last year, Medicare would have saved $12 billion, which ...

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

The Centers for Medicare and Medicaid Services on Tuesday announced lower prices on 15 costly prescription drugs under ...

The Trump administration tapped a Biden-era rule to negotiate lower prices on 15 widely used medications for seniors.

The United States has revealed price reductions for the second round of | The U.S. has revealed price reductions for the ...

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of ...